エピソード

  • 3 Things You Should Know About Interventional Glaucoma Comanagement
    2025/06/04
    Glaucoma is a leading cause of irreversible blindness and affects approximately 80 million people globally, with projections to exceed .111 million by 2040. We know that the elevated intraocular pressure is the key modifiable risk factor which is why reducing intraocular pressure is central to treatment strategies.

    In this podcast, expert faculty from the featured symposium at the 2025 EnVision Summit share insights about interventional glaucoma co-management.

    Those faculty include ophthalmologists Rachel Simpson from Moran Eye Center in

    Salt Lake City, UT; James Murphy from Connecticut Eye Physicians in New Haven, CT; Mary Qiu from the Cleveland Clinic’s Cole Eye Institute in Cleveland, Ohio; and optometrist Jessica Steen from the Nova Southeastern University College of Optometry in Fort Lauderdale, FL.
    続きを読む 一部表示
    32 分
  • 3 Things You Should Know About Early Treatment Intervention for TED
    2025/05/30
    Thyroid eye disease (TED), a rare autoimmune condition, can be sight-threatening, debilitating, and disfiguring, severely impacting patients’ quality of life and daily functioning. Traditional management approaches for TED have centered on immunomodulatory therapy and surgical interventions. In January 2020, the US Food and Drug Administration (FDA) approved teprotumumab, the first therapy specifically indicated for TED. As treatment options evolve, there is an increasing need for a patient-centered, multidisciplinary approach, which is essential to address individual patient needs throughout the disease course.

    This PER On Air Ophthalmology Times podcast provides an in-depth review of some of the key highlights from a satellite symposium that took place at the Envision Summit 2025 meeting in February 2025. This unique and engaging activity focuses on the practical aspects of managing patients with thyroid eye disease, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
    続きを読む 一部表示
    16 分
  • Patient-Centered Treatment Strategies in the Management of nAMD and DME
    2025/05/30
    Recently approved anti-VEGF agents that target additional pathways and offer innovative delivery methods with longer-lasting effects may provide advantages over older anti-VEGF agents in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this podcast, expert faculty discuss the roles of ophthalmologists and optometrists in managing nAMD and DME in an evolving treatment landscape, from screening and diagnosis to referral and ongoing patient care.
    続きを読む 一部表示
    14 分
  • 3 Things You Should Know About the GA Pipeline
    2025/05/30
    Geographic atrophy, an advanced stage of age-related macular degeneration, is a significant cause of vision loss. Given the progressive nature of geographic atrophy and its significant impact on quality of life, educating health care professionals about the disease burden, diagnostic strategies, and evolving management strategies is essential.

    This PER On-Air Ophthalmology Times podcast provides an in-depth review of some of the key highlights from the Envision Summit 2025 meeting, held in February 2025. This unique and engaging activity focuses on the practical aspects of managing patients with geographic atrophy, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
    続きを読む 一部表示
    9 分
  • The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery
    2025/05/29
    The lacrimal functional unit, which includes the lacrimal glands and meibomian glands, can be stimulated via the trigeminal nerve to trigger production of the tear film. This approach can be used to manage dry eye disease (DED) in patients undergoing corneal refractive surgery. In this podcast, an expert explores opportunities to use this approach to treat patients with DED.
    続きを読む 一部表示
    12 分
  • California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education in San Francisco
    2024/12/13
    The 14th annual Glaucoma 360 conference will take place February 6 to 8, 2025, at the Westin St. Francis on Union Square in San Francisco, California. Co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, the three-day event highlights progress in glaucoma care while fostering innovation and collaboration.

    The conference opens on Thursday, February 6, with a gala to celebrate advancements in the field, followed by the New Horizons Forum on Friday, February 7, which serves as an incubator for innovation. Topics include artificial intelligence in glaucoma management, neuroprotection and vision restoration, and cross-species insights from veterinary ophthalmology. Carla J. Siegfried, MD, president of the American Glaucoma Society, will deliver the keynote address.

    The program on Saturday, February 8, begins with a continuing medical education program featuring M. Roy Wilson, MD, MS, who will present the Shaffer-Hetherington-Hoskins Lecture, and concludes with an optometric symposium. Visit www.glaucoma360.org for details.


    続きを読む 一部表示
    7 分
  • EnVision Summit 2025: Family-centric conference unites ophthalmology and optometry for learning and leadership
    2024/11/17
    The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-friendly, multispecialty CME ophthalmology conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times' Sheryl Stevenson, group editorial director - eye care, to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.

    Henderson describes the meeting as “a place where not only are physicians and optometrists learning, but their families are part of the experience too,” emphasizing the opportunity for personal and professional growth in a supportive, community-oriented environment.

    The 2025 agenda will include symposia, surgical videos, panel discussions, and leadership seminars that highlight rapid advancements across ophthalmology specialties, including cataract, refractive, retina, glaucoma, pediatrics, and oculoplastics. “It’s incredible how quickly things change in ophthalmology—if you miss a year or two, you’ll be amazed by the innovations that have emerged,” Henderson shared. Updates on new intraocular lenses, surgical tools, and diagnostic techniques will showcase the field’s forward momentum. Additionally, a leadership seminar led by Malvina Eydelman, MD, Director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices at FDA, Silver Spring, Maryland, will feature discussions on career pathways and diversity, empowering attendees with insights from industry leaders.

    The optometry track, introduced last year, continues to expand, emphasizing collaboration between ophthalmologists and optometrists in critical areas like preoperative and postoperative care, medications, and diagnostic tools. As Henderson explained, “It's important for both fields to come together and discuss how we can work together to improve patient care.” This cross-disciplinary dialogue reflects the summit's dedication to advancing care through shared expertise.

    The youth program offers age-appropriate activities that allow children to engage in fun learning while also witnessing their parents' professional contributions. "It’s amazing to watch these kids grow up at EnVision Summit and form lasting friendships,” said Henderson. The trainee program, which offers free registration for residents, fellows, and medical students, has also seen growth. Henderson highlighted the program’s value, noting that it “gives young professionals the chance to network with leaders in the field and gain invaluable mentorship.”

    To learn more about or to register for EnVision Summit 2025, click here.
    続きを読む 一部表示
    14 分
  • AI in ophthalmology: Putting the buzz of large language models into perspective with Robert T. Chang, MD
    2024/11/06
    Robert T. Chang, MD, from Stanford University discusses the evolving role of large language models (LLMs) in glaucoma care. He explores how these AI tools, including popular systems like ChatGPT, can enhance communication and patient education by summarizing complex information and tailoring it to different literacy levels.

    Chang highlights the potential of LLMs in improving efficiency in ophthalmology practices, such as assisting with virtual scribing and streamlining patient communication. However, he cautions about the risks of "hallucinations," where the AI may generate inaccurate information, stressing the importance of verification.

    Chang also touches on the use of LLMs for training medical residents and fellows, noting how they can simulate realistic scenarios, like preparing for fellowship interviews. Overall, he emphasizes that while LLMs offer significant benefits, careful use and validation are crucial for safe and effective integration into clinical workflows.


    続きを読む 一部表示
    20 分